In a study of CAFs in NSCLC patients, CAFs with high expression of both HGF and FGF7, and CAFs with high expression of FGF7 were found to be differentially protective against tumors, and were associated with the immune microenvironment of tumors [92]. This evidence concerns the gene HGF and non-small cell lung carcinoma.